TILOBRASTIL õhukese polümeerikattega tablett Estonia - Esti - Ravimiamet

tilobrastil õhukese polümeerikattega tablett

sandoz pharmaceuticals d.d. - tikagreloor - õhukese polümeerikattega tablett - 60mg 168tk; 60mg 180tk; 60mg 14tk

TILOBRASTIL õhukese polümeerikattega tablett Estonia - Esti - Ravimiamet

tilobrastil õhukese polümeerikattega tablett

sandoz pharmaceuticals d.d. - tikagreloor - õhukese polümeerikattega tablett - 90mg 168tk; 90mg 100tk; 90mg 56tk; 90mg 180tk; 90mg 14tk

ATIXARSO õhukese polümeerikattega tablett Estonia - Esti - Ravimiamet

atixarso õhukese polümeerikattega tablett

krka d.d. novo mesto - tikagreloor - õhukese polümeerikattega tablett - 60mg 14tk; 60mg 180tk; 60mg 56tk; 60mg 168tk; 60mg 60tk

ATIXARSO õhukese polümeerikattega tablett Estonia - Esti - Ravimiamet

atixarso õhukese polümeerikattega tablett

krka d.d. novo mesto - tikagreloor - õhukese polümeerikattega tablett - 90mg 14tk; 90mg 60tk; 90mg 168tk; 90mg 180tk

Vazkepa Uni Eropa - Esti - EMA (European Medicines Agency)

vazkepa

amarin pharmaceuticals ireland limited - icosapent ethyl - düslipideemiad - lipiidi modifitseerivad ained - indicated to reduce cardiovascular risk as an adjunct to statin therapy.

Plerixafor Accord Uni Eropa - Esti - EMA (European Medicines Agency)

plerixafor accord

accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - immunostimulants, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.

Eladynos Uni Eropa - Esti - EMA (European Medicines Agency)

eladynos

theramex ireland limited - abaloparatide - osteoporosis, postmenopausal; osteoporosis - kaltsiumi homöostaas - osteoporoosi ravi postmenopausis naistel, kellel on suurem luumurdude risk.

PLERIXAFOR AUXILIA süstelahus Estonia - Esti - Ravimiamet

plerixafor auxilia süstelahus

auxilia pharma oÜ - pleriksafoor - süstelahus - 20mg 1ml 1.2ml 1tk

TICAGRELOR ELVIM õhukese polümeerikattega tablett Estonia - Esti - Ravimiamet

ticagrelor elvim õhukese polümeerikattega tablett

sia elvim - tikagreloor - õhukese polümeerikattega tablett - 90mg 56tk

TICAGRELOR FARMAPROJECTS õhukese polümeerikattega tablett Estonia - Esti - Ravimiamet

ticagrelor farmaprojects õhukese polümeerikattega tablett

farmaprojects s.a.u. - tikagreloor - õhukese polümeerikattega tablett - 60mg 168tk; 60mg 56tk